Diffuse Large B-cell Lymphoma Refractory
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma Refractory.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Zanubrutinib+Lenalidomide+R-ICE in Relapsed/Refractory DLBCL [Phase 2]
Phase 2 clinical trial evaluating zanubrutinib, lenalidomide, and R-ICE in relapsed/refractory diffuse large B-cell lymphoma.